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POPULÄRVETENSKAPLIG SAMMANFATTNING 
 
Genen MYCN kodar för N-Myc, ett protein som fungerar som transkriptionsfaktor, det vill 
säga det kontrollerar vilka gener som transkriberas aktivt från DNA till RNA. Många 
neuroendokrina tumörer, speciellt neuroblastoma, uppvisar ofta onormalt höga nivåer av N-
Myc, och eftersom N-Myc startar transkriptionen av många gener som är viktiga för cellens 
delning, tillväxt och mobilitet, skulle det kunna vara en bidragande orsak till cancerutveckling. 
Både genens och proteinets struktur är mycket lika de för det närbesläktade c-Myc, med 
undantag för den 3´icke-translaterade regionen (3´UnTranslated Region, 3´UTR). När 
messenger RNA (mRNA) translateras till protein är det inte allt som kodar för protein och den 
icke-kodande sekvensen som ligger efter mRNAts stopkodon kallas 3´UTR. Att just den 
sekvensen skiljer sig så mycket mellan N-Myc och c-Myc antyder att den skulle kunna vara 
viktig när det gäller bestämmandet av det vitt skillda uttrycket mellan dem, speciellt med 
tanke på att 3´UTR är den regionen som är utsatt för den största andelen av mRNA reglering. 
MicroRNA (miRNA) är små, icke-kodande RNA som binder till 3´UTR och förhindrar 
translation av mRNA. Datorbaserade algoritmer kan förutsäga vilket mRNA som de binder 
till, men dessa beräkningar tycks göra en grov överskattning av deras antal. Datorprogrammen 
är därför en bra indikation på vilka interaktioner som skulle kunna ske, men de kan inte ge 
någon säker information. Inbindningssekvenserna för flera intressanta miRNA är beräknade 
till att befinna sig i MYCNs 3´UTR och skulle kunna föklara dess reglering. Vissa av dessa 
miRNA är sedan tidigare kända för att reglera cellulära processer med motsatt utgång i 
förhållande till N-Myc. Vissa ligger i en kromosomal region som ofta har blivit förlorad i 
neuroblastoma celler. Ifall det skulle visa sig att de förhindrar N-Myc protein från att bildas 
skulle detta ge en klarare av hur N-Myc interagerar i cellen. För att undersöka detta sattes här 
olika delar av MYCNs 3´UTR in nedanför eldfluge-luciferasgenen på en plasmid. Plasmider är 
små cirkulära DNA-molekyler som kodar endast för ett fåtal protein. Luciferas är ett enzym 
som skapar luminiscens och dess aktivitet kan mätas med en luminometer. När MYCN 3´UTR 
sätts in efter dess stopkodon påverkar regleringen av denna (t.ex genom miRNA) hur mycket 
av luciferasets mRNA som hindras från att translateras. På detta sätt skapades en 
reporterplasmid som visar hur MYCN skulle kunna regleras av miRNA när den transfekteras 
in i humana celler.Transfektion med en miRNA prekursor eller inhibitor av samma cell som 
har plasmiden kan visa effekten av denna på mängden luciferasprotein. Renilla-luciferas, ett 
annat luciferas från sjöpennan Renilla reniformis används som en kontroll för 
transfektioneffektiviteten. Denna kodas antingen från samma plasmid eller från en helt annan. 
Tre olika plasmider konstrurerades i detta syfte och testades med siRNA, en motsvarigheten 
till miRNA som ofta används för att på konstgjord väg blockera translationen av det mRNA 
de binder till. 
 
ABSTRACT 
 
The gene MYCN encodes a transcription factor with a fundamental role in many 
neuroendocrine tumors, especially neuroblastoma. The gene and protein are very similar to 
the closely related c-Myc protein, except for the 3´untranslated region (3´UTR), suggesting 
that it may be an important factor in determining their very different expression pattern at the 
post-transcriptional level. MicroRNA (miRNA) are small non-coding RNA that bind to the 
3´UTR and prevent translation of their target mRNA. Targets can be predicted with 
computational algorithms, but the number of targets seems to be greatly overestimated. The 
target sequence of several interesting miRNAs exist in the MYCN 3´UTR that may explain its 
regulation and deregulation. To test if these targets are true, an in vitro approach with a 
plasmid-encoded reporter gene can be used. Here, the MYCN 3´UTR has been inserted 
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downstream of the firefly luciferase gene. Renilla luciferase, on the same plasmid or separate, 
is used as a control. Three plasmids with different insert lengths were generated.
INTRODUCTION 
 
MYC transcription factors (c-Myc, L-Myc 
and N-Myc) are critical regulators of the 
cell cycle by promoting proliferation. c-
Myc was described first and is most deeply 
studied, but N-Myc seem to be able to 
replace c-Myc in almost all settings (Aubry 
et al. 2000, Malynn B.A. et al.), suggesting 
redundancy, and that they function 
differently only because of variations in 
their temporal and spatial expression. N-
Myc is critical during development, but 
becomes restricted to specific tissues, such 
as the brain, testis and heart in adults (Xu 
et al. 1991). In addition to their 
proliferative capabilities, MYCs seem to 
equip cancer cells with all properties 
required; such as enhancing DNA 
replication (Dominguez-Sola et al. 2007), 
favoring glycolysis (Morish et al. 2008) 
and facilitating metastasis (reviewed by 
Eilers and Eisenmann 2008). Hence, 
MYCs are notorious oncogenes.  
 
Although the functions of MYCs seem to 
be similar, their regulation must be 
different and studies have to be done on 
each MYC in this context. The malignancy 
most characteristic for N-Myc is 
neuroblastoma (Schwab 2004), a paediatric 
tumor believed to develop from migrating 
neural crest cells that fail to differentiate. 
Neuroblastoma is responsible for approx. 
15% of childhood cancer deaths. The 
critical role of N-Myc is well established, 
high protein levels is a direct cause (Weiss 
et al. 1997) and MYCN amplification 
correlates with very poor prognosis. In this 
context, revealing the regulation 
mechanisms of N-Myc protein levels are of 
great value. In addition to transcription, 
control of MYC protein levels is likely 
very important also at post-transcriptional 
level. MYC transcripts are very similar, the 
only exception being the 3´untranslated 
region (3´UTR) that is much longer in 
MYCN (N-Myc) than MYC (c-Myc) 
(Stanton et al. 1986). Conceivably, the 
3´UTR is the major contributor to 
differences in their post-transcriptional 
regulation.  
 
MicroRNAs (miRNAs) are non-translated 
small RNAs (22 nucleotides) that regulate 
cellular protein levels by inhibiting 
translation or reducing the stability of 
mRNA by one or several mechanisms 
(reviewed by Kutter and Svoboda 2008, 
Eulalio et al. 2008). The miRNA seed 
region, generally consisting of nucleotides 
2-8 from the 5´ end, is highly conserved 
and crucial for target recognition. Animal 
miRNAs bind only to the 3´UTR, perhaps 
because it lacks scanning or translating 
ribosomes that otherwise disrupt binding 
(Gu et al. 2009). Recent data however, 
suggests that there can be interactions in 
the coding sequence (CDS) as well 
(Elcheva et al. 2009), perhaps because of 
rare codons upstream that slow downs the 
ribosomes or alternatively by interactions 
with different proteins (Ago2 instead of 
Ago1). In any case, so far, this can be 
viewed as an exception rather than a rule 
and by restricting targeting to the 3´UTR 
the number of possible targets is greatly 
diminished. Furthermore, as mentioned 
above, the 3´UTR can be suspected to be 
participating profoundly in regulation of 
protein synthesis. Targets of a particular 
miRNA can be predicted using one of 
many internet based programs, but all have 
in common that they greatly overestimate 
the number of true targets (reviewed by 
Mendes et al. 2009). Factors that may 
contribute to in vivo and in vitro functions 
include mRNA structure (Long et al. 2007) 
and the presence of RNA binding proteins 
(Reviewed by Glisovic et al. 2008).  
 
Reporter systems utilizing Firefly 
luciferase (Fluc) from Photinus pyralis are 
perhaps the most effective for measuring 
regulation of a nucleotide sequence in vitro 
(Fan and Wood 2006). Benefits of Fluc are 
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the high sensitivity and high dynamic 
range. Fluc is often used together with 
Renilla luciferase (Rluc) from Renilla 
reniformis. FLuc and Rluc can be used to 
validate a predicted miRNA target by 
inserting the sequence downstream of the 
luciferase stop codon. Cotransfecting 
synthetic miRNA precursors or inhibitors 
would then give the expected effect on 
luciferase protein levels and luminescence 
activity. Because Rluc uses a different 
substrate, coelenterazin instead of luciferin, 
it can be used together with Fluc as a 
measurement of transfection effiency. For 
convenience, Fluc and Rluc could be 
encoded on the same plasmid. In theory, 
this would also give a more reliable system. 
However, it is possible that it could be 
limiting when the amount of each enzyme 
cannot be manipulated with different 
amounts of transfected plasmid. Therefore, 
two vector backbones were utilized for 
creating MYCN 3´UTR constructs; one 
with Fluc, and one encoding both Fluc and 
Rluc.    
 
To make sure that the silencing is not 
artificial, as much as possible of the 
sequences surrounding the predicted target 
site should be included in the vector. If 
cloning not much more than the target site, 
a downregulation is not much more 
validating than a computational target 
prediction. A natural choice is to insert the 
full 3´UTR. This will give the most native 
three-dimensional mRNA structure and 
target site availability. Although the 
predicted target site is included, and 
perhaps will be validated with site-directed 
mutagenesis, excluding surrounding 
sequences may disrupt binding sites for 
RNA-binding proteins. Many RNA 
binding proteins influence RNAi and their 
binding sites do not need to be directly 
linked to the miRNA target site (Elcheva et 
al. 2009). The correct distance between the 
end of ribosomal activity (the stop codon) 
and the target site is also important (Bartel 
2009). Including upstream bases of the 
coding sequences in the insert will perhaps 
give a correct nucleotide arrangement, but 
if the luciferase stop codon is not removed, 
the 3´UTR will be an artificial elongated 
version that could harbour additional target 
sites. By using insets with different 
surrounding sequences, a hint of potential 
regulatory elements can be given and 
direct further investigations on the full 
3´UTR.     
 
METHODS 
 
Polymerase Chain Reaction (PCR) 
The MYCN 3´UTR (Figure 1) was 
amplified using three different sets of 
primers (1-3 Table 1). Two of the PCR 
products (inserts 1 and 2) were engineered 
with SacI and HindIII restriction sites for 
cloning into the pMIR-REPORT 
Expression Vector (Ambion). The size of 
these fragments differed greatly; inserts 1 
included the full 3´UTR while insert 2 was 
only the middle part of the 3´UTR 
(nucleotides 276-650). Insert 1 had 7bp 
upstream and 13 bp downstream, giving a 
total size of 936 bp after restriction 
cutting). Approximately the same, full 
sequence  but with one nucleotide missing 
upstream and 4 bp downstream was 
produced by the third primer pair 
(fragment size 918 bp), but with sites for 
NheI and SalI for cloning into the pmir Glo 
Dual Luciferase Expression Vector 
(Promega). Both plasmid backbones 
contain the -galactosidase encoding gene 
(amp
r
), making ampicillin selection 
possible.  
 
A DNA template was extracted from cells 
of the human neuroblastoma cell line 
LAN-1, using a Genomic DNA 
Purification Kit (Fermentas) according to 
the manufactures instructions. MYCN is 
greatly amplified in this cell line, rendering 
it a promising template for primers 
targeting the MYCN gene.  
 
For the PCR, Fermentas PCR Master Mix 
(2X) was used. To optimize the PCR 
different volumes of 25 mM MgSO4 
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(Fermentas) was added. The PCR program 
for primer pairs 1 and 2 was as follows: 
initial denaturation, 94 ˚C for 2 min; 
denaturation 94 ˚C for 1 min; annealing, 
55˚C for 1 min; elongation 72 ˚C for 1.5 
min; final elongation, 72˚C for 10min. 
Primer pair 3 used the following program: 
initial denaturation, 94 ˚C for 2 min; 
denaturation 94 ˚C for 1 min; annealing, 50 
˚C for 1 min; elongation 72 ˚C for 1 min; 
final elongation, 72 ˚C for 10 min. The 
number of cycles of both programs was 25.  
 
Samples were analyzed with agarose gel 
electrophoresis using Tris-Acetate EDTA 
(TAE) buffer (4.84 g tris base, 1.14 ml 
glacial acetic acid, 100 ml EDTA (pH = 8), 
and 1% agarose in the gel, and a final 
concentration of 10 g ethidium bromide 
per ml TAE buffer. After optimizing the 
PCR, the products were purified directly 
using QiaQuick PCR Purification Kit 
(Qiagen) without prior gel purification. 
This gave greater yield compared to gel 
excision and purification using QiaQuick 
Gel Extraction Kit (Qiagen). 
 
Molecular Cloning 
pMIR-REPORT vector and inserts 1 and 2 
were double digested with FastDigest 
HindIII (Fermentas) and FastDigest SacI 
(Fermentas) according to the manufactures 
protocol but with  slightly longer 
incubation of approx. 15 min, followed by 
inactivation for 5 min in 65 ˚C. Shorter 
digestion times (5min) were not tested 
however. The pmir Glo vector and insert 3 
were double digested with FastDigest SalI 
(Fermentas) and  
FastDigest NheI (Fermentas) as above. In 
the case of pmir Glo, the cleaved plasmid 
was purified with agarose gel 
electrophoresis and extracted using 
QiaQuick Gel Extraction Kit (Qiagen).  
 
Ligations, using T4 DNA ligase 
(Fermentas) were carried out overnight in 
the case of inserts 1 and 2. Insert 3 was 
incubated with linearized pmir Glo vector 
for 2 h. All reactions were carried out at 
room temperature and inactivated at 65 ˚C 
for 10 min. The mass ratio (insert:vector) 
was 1:1 in both cases. This gives a molar 
ratio of approx. 6:1 and 7:1, respectively.  
 
 
 
 
A) 
  
B) 
5´-   1 
61 
121 
181 
241 
301 
361 
421 
481 
541 
601 
661 
GCTTCTCAAAACTGGACAGTCACTGCCACTTTGCACATTTTGATTTTTTTTTTAAACAAA 
CATTGTGTTGACATTAAGAATGTTGGTTTACTTTCAAATCGGTCCCCTGTCGAGTTCGGC 
TCTGGGTGGGCAGTAGGACCACCAGTGTGGGGTTCTGCTGGGACCTTGGAGAGCCTGCAT 
CCCAGGATGCTGGGTGGCCCTGCAGCCTCCTCCACCTCACCTCCATGACAGCGCTAAACG 
TTGGTGACGGTTGGGAGCCTCTGGGGCTGTTGAAGTCACCTTGTGTGTTCCAAGTTTCCA 
AACAACAGAAAGTCATTCCTTCTTTTTAAAATGGTGCTTAAGTTCCAGCAGATGCCACAT 
AAGGGGTTTGCCATTTGATACCCCTGGGGAACATTTCTGTAAATACCATTGACACATCCG 
CCTTTTGTATACATCCTGGGTAATGAGAGGTGGCTTTTGCGGCCAGTATTAGACTGGAAG 
TTCATACCTAAGTACTGTAATAATACCTCAATGTTTGAGGAGCATGTTTTGTATACAAAT 
ATATTGTTAATCTCTGTTATGTACTGTACTAATTCTTACACTGCCTGTATACTTTAGTAT 
GACGCTGATACATAACTAAATTTGATACTTATATTTTCGTATGAAAATGAGTTGTGAAAG 
TTTTGAGTAGATATTACTTTATCACTTTTTGAACTAAGAAACTTTTGTAAAGAAATTTAC 
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721 
781 
841 
901 
TATATATATATGCCTTTTTCCTAGCCTGTTTCTTCCTGTTAATGTATTTGTTCATGTTTG 
GTGCATAGAACTGGGTAAATGCAAAGTTCTGTGTTTAATTTCTTCAAAATGTATATATTT 
AGTGCTGCATCTTATAGCACTTTGAAATACCTCATGTTTATGAAAATAAATAGCTTAAAA 
TTAAATGA  - 3´ 
 
Figure 1. A) The MYCN gene consists of three exons. Nothing of the first exon is translated, and the 5´UTR is 
unusually long. All MYCs share these gene arrangements. In contrast, the 3´UTR of MYCN in the last exon is 
much longer than that of MYC. B) The DNA sequence of the MYCN 3´UTR. Inserts 1 and 3 included the full 
3´UTR plus some additional basepairs. Insert 1 had 7 bp extra upstream and 13 bp downstream, and insert 3 had 
one nucleotide missing upstream and 4 bp extra downstream. The sequence indicated in bold is insert 2.  
 
Table 1. Primer pairs. The numbers 1-3 corresponds to the numbers of the PCR products 1-3. Engineered 
restriction sites are underlined. Sequences are written in 5´ to 3´ direction. 
 
Bacterial cell culture 
Escherichia coli cells of the strain JM-106 
were grown in a rotating incubator at 37 ˚C 
in Luria Bertani (LB) media composed of 
(per liter) 10 g Tryptone, 10 g NaCl and 5 
g yeast extract. The media was also 
supplied with amplicillin to a final 
concentration of 100 g/ml.    
 
An overnight 5 mL culture of JM-106 was 
put into a baffled flash containing 1 litre 
LB media and grown to an OD of 5.6. At 
this point, cells were harvested by 
centrifugation and resuspended in a total 
volume of 600 ml 10 % cold glycerol. 
After a second centrifugation for 15 min, 
the pellet was resuspended in 14 ml 10 % 
glycerol and spun down for 20 min. 500 l 
10 % glycerol was used to resuspend the 
pellet and the cells were stored as aliquotes 
of 50 l in -80 ˚C.  
 
50 l JM-106 was transformed with approx. 
40 ng of plasmid directly from the ligation 
mixtures using electroporation. The 
transformation was followed by an hour of 
phenotyping in 1 mL LB media without 
ampicillin.150 L of the transformation 
mix was plated on ampicillin-containing 
agar plates and grown overnight. Colonies 
were checked for insert with colony PCR 
using the same primer pair that yielded 
insert number 2 (giving a 374 bp fragment). 
Positive colonies were further analyzed 
with restriction cutting using the same 
enzymes that provided the sticky ends for 
ligation. The plasmids were confirmed by 
sequencing (Eurofin MWG Operon). 
Plasmids were propagated in JM-106 
grown in LB media with ampicillin and 
purified using GeneElute HP Plasmid 
Midiprep (Sigma) and GeneJet Plasmid 
Miniprep Kit (Fermentas).  
 
Human cell culture 
Human non-cancerous breast epithelial 
HB-2 cells were grown in a humidified 
atmosphere with 5 %CO2. The medium 
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was composed of 450 mL Dulbecco´s 
Modified Eagle Medium (DMEM) 
supplied with 10 % Fetal Bovine Serum 
(FBS), 1 % L-glutamine, 1 % penicillin 
and streptomycin, 0.1 % insulin and 0.1 % 
hydrocortisone.  
 
Transfection 
On day prior to transfection, HB-2 cells 
were seeded in 24-well plates. The cells 
were transfected with the empty vectors or 
with vectors containing the constructs 
using Lipofectamine 2000 (Invitrogen). 
siRNA targeting the MYCN 3´UTR was 
cotransfected. 40 h after transfection, cells 
were treated with Passive Lysis Buffer 
(Promega) according to the manufactures 
recommendations and were then stored at -
20 ˚C until analysis. The cell lysates were 
measured for luciferase activity with a 
Bioorbit 1250 Luminometer and using 
Promegas Dual-Glo Luciferase Assay 
System. In brief, substrates for Fluc 
activity are first added and luminescence is 
measured. The reaction is then quenched at 
the same time as Rluc reactants are added, 
and luminescence is measured again. The 
ratio between Fluc and Rluc activity is 
used to eliminate variance in transfection 
effiency.    
 
RESULTS  
 
Generation of plasmids 
The transformation yielded approx. 10-20 
colonies at a time, of which almost all 
were sceened with colony PCR. Of these 
more than half (insert 3) or a third (insert 1 
and 2) were positive. The colony PCR 
(Figure 2) results correlated well with 
subsequent restriction cutting (Figure 3).   
 
Sequencing 
Sequencing revealed that DualGlo-MYCN 
lacked an adenosine at position 730 and a 
thymine at 731 in the MYCN 3´UTR. This 
is likely a true mutation since it was 
identified by sequencing in both direction 
of the two different strands and there was 
nothing suspicious with the chromatogram. 
No predicted miRNA site lies within this 
region (MiRanda, miRBase). 
 
A.                                                         B. 
Figure 2. Agarose gels of colony PCRs. A) Colony PCR after electroporation with ligation mixture with pmir 
Glo and insert 3. The numbers represent the colonies, which were all that were analyzed at this step. Plasmid 
DNA from the colonies that gave the strongest bands was purified with miniprep. B) Part of a gel from colony 
PCR with transformants suspected to have insert 1 or 2. The DNA marker ladders are the same in all pictures 
(1kb DNA Gene Ruler (Fermentas)).     
           
         A.                       B.                        C.           
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Figure 3. Restriction cleavages. The restriction sites engineered in the primers were used to excise the fragments. 
Insert 1 is 936 bp, insert 2 is 374 bp and insert 3 is 918 bp. A) Restriction cleavage of purified plasmid from 
colonies that were checked with PCR and labelled Insert 2B and Insert 1 in picture 2B. This gel showed insert 
2B as a negative, but when it was checked again (3B) it became clear that this was due to improper cutting. B) 
Restriction cleavage of purified plasmid from colonies that were checked with PCR and labelled Insert 2A and 
Insert 2B in picture 2B. C) Restriction cleavage of the purified plasmids from colonies 1, 3, 5, 6, 7, 8 and 10 
(upper) of the gel in 2A. All except number 5 were positive, but it looks like it was also positive and just poorly 
cleaved. The DNA marker ladders are the same in all pictures (1 kb DNA Gene Ruler (Fermentas)).
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1.                                                                             2. 
 
3.  
 
 
Figure 4. The three plasmid constructs containing 
the MYCN 3´UTR or part of it. The two upper 
plasmids were created from a pMIR-REPORT 
backbone, while the third is derived from the pmir 
Glo vector.   
 
siRNA knockdown of firefly luciferase 
To test the function of the plasmids, three 
different siRNA (named scramble, siRNA1 
and siRNA2 in Figure 4) were employed. 
siRNA 1 and siRNA 2 were constructed to 
target the MYCN 3´UTR in a region that 
was included in all inserts. Luciferase 
activity was also measured without siRNA. 
Firefly luciferase (Fluc) activity was 
normalized against Renilla luciferase 
(Rluc). Rluc was expressed from a 
cotransfected plasmid in the case of Fluc-
MYCN and Fluc-MYCN-276-650. 
DualGlo-MYCN expresses both 
luciferases and cotransfection was not 
necessary. As shown in Figure 5, the 
scrambled control gave the same result 
with or without the insert, while the other 
siRNAs gave a strong downregulation, 
especially siRNA 2 against insert 2 (9-
fold). On the other hand, siRNA 2 against 
insert 3 was not very efficient.  
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Figure 5. Luciferase activity of cell lysates after 
transfection of 5 different plasmids. The two empty 
vectors (blue and black) were also tested with 
siRNA. siRNA1 and siRNA2 targets the MYCN 
3´UTR. Control is without siRNA, scramble is a 
siRNA targeting another region of MYCN that was 
not in the inserts.  
 
DISCUSSION 
 
Since the discovery of endogenous RNAi 
(i.e. miRNA) (Lee et al. 1993, Wightman 
et al. 1993), the 3´UTR has drawn much 
attention because of the extensive post-
transcriptional control of mRNA and 
protein levels that is at work in this region. 
Here, luciferase constructs with parts of or 
the complete 3´UTR of the oncogene 
MYCN are presented (Figure 4). MYCN 
encodes a transcription factor with 
functions in neuronal development and 
great clinical importance in the treatment 
of some cancers, in particular 
neuroblastoma, but also other 
neuroendocrine tumors that include a large 
proportion of all lung cancers. The 
evolutional sequence divergence of the 
MYCN 3´UTR suggests that it has 
important functions that specifies N-Myc 
expression. However, little of this has been 
revealed so far.   
 
The reporter vectors created here can be 
used in many ways to quickly validate a 
miRNA as a regulator of N-Myc. In a 
miRNA-gain-of-function approach, 
synthetic miRNA precursors can be 
cotransfected. In a loss-of-function 
approach, miRNA inhibitors (antagomirs) 
are used. Alternatively, the effect of the 
reduction of whole groups or the complete 
population of miRNA can be tested, as 
well as the modulation of cellular 
processes and interactions with the 
environment (an overview of miRNA 
techniques is given by Wang 2009). All 
such modifications can give information of 
what mechanisms could confer abnormal 
N-Myc levels through the 3´UTR.     
 
To my knowledge, only one miRNA has 
been validated as a direct repressor of 
MYCN, i.e. miR-34a (Wei et al. 2008). 
Interestingly, miR-34a is located in a band 
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of the short arm of chromosome 1 
(1p36.term-1p36.2) that is commonly 
deleted in neuroblastoma (Mosse et al. 
2007). Thus, miR-34a is likely to be 
involved in the pathology. Furthermore, 
members of the miR-200 family are 
clustered in the same region and predicted 
to target MYCN. The same study (Wei et al. 
2008) also investigated the effect of these 
miRNAs on growth, but due to their 
modest effect compared to miR-34a, the 
study went further only with miR-34a. It 
should be noted though that miR-34a also 
targets some other regulators of cell 
viability (Tazawa et al. 2007), and 
somehow enhances the activity of p53 
(Yamakuchi and Lowenstein 2009). It is 
possible that p53 and others have a greater 
influence on cellular growth than N-Myc 
and was responsible for much of the effect 
of miR-34a. miR-200s are notorious 
regulators of epithelial-to-mesenchymal 
transition (EMT) (Park et al. 2008, Hurteau 
et al. 2007), a process that facilitate 
metastasis. Invasiveness is a characteristic 
of the most severe neuroblastomas (Killion 
and Fidler 1989). Both clinical data 
(Seeger et al. 1985) and molecular studies 
(Goodman et al. 1996, Janardhanan et al. 
2009) suggest that N-Myc has a prominent 
role in mobility gain of neuroblastomas. It 
is possible that another specification of 
miR-200s control of EMT involves N-
Myc-controlled cell functions, and that the 
loss of the short arm of chromosome 1 
releases their regulation of MYCN. Hence, 
it would be interesting and more 
informative to test if miR-200 actually 
targets MYCN in vitro.    
 
Neuronal precursors have stem cell 
properties, show glial characteristics and 
exist also the human brain (reviewed by 
Kriegstein et al. 2009). The glial 
precursors, radial glia, differentiate into 
various intermediate precursor cells 
depending on their final cell type. N-Myc, 
in contrast to its proliferative and 
otherwise differentiation-repressive 
features, promotes neuronal differentiation 
into intermediate precursors of neurons, 
neuroblasts (Wakamatsu et al. 1997). 
These are maintained in a proliferative 
state by N-Myc (Nagano et al. 2009). 
During final differentiation into quiescent 
neurons, N-Myc is downregulated. Likely, 
miRNAs are part of the process. 
 
Some of the most well-understood 
miRNAs, members of the let-7 family, are 
among the most crucial factors modulating 
stem cell properties, and have been 
connected to c-Myc. Let-7 targets c-Myc 
(Sampson et al. 2007), but there is also a 
dual relationship, because c-Myc induces 
Lin28 that prevents let-7 processing. Let-7 
is expressed in terminally differentiated 
neurons (Wulczyn et al. 2007). c-Myc, 
perhaps interchangeable with N-Myc, is 
one of the four factors needed to 
artificially produce induced pluripotent 
stem cells (iPSs) (reviewed by Konrad and 
Plath 2009). Lin-28, however, can 
substitute for c-Myc, and is necessary for 
this function, suggesting that it is the major 
downstream actuator for this function 
(Chang et al. 2009). c-Myc widely 
represses miRNA expression (Chang et al. 
2008), giving a possible explanation for 
the induced pluripotency, but except for 
let-7, Lin-28B seems not to be much 
involved in this regulation. Hence, let-7 
could be one of the most critical molecular 
regulators of stem cell maintenance. 
Recently, N-Myc was found to induce Lin-
28B in neuroblastoma cells (Cotterman 
and Knoepfler 2009). A cell culture 
population of neuroblastoma cells contain 
approx. 10% multipotent cells, and they 
may be fundamental for invasive and 
proliferative potential of the tumor 
population. Although MYC (c-Myc) and 
MYCN 3´UTRs differ greatly, MYCN 
harbours two predicted target sites for let-7 
(using Target-Scan), one of which shows 
additional 3´complimentarity to some let-7 
members, something that is believed to 
strengthen repression. The 3´ part of the 
mature miRNA is also suggested to be the 
distinguishing factor of which different 
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mRNA targets are regulated by different 
let-7 members (Bartel 2009). Hence, this 
predicted target site is particulary 
interesting when it comes to potential 
regulation discrimination between MYC 
and MYCN. Future studies will reveal if a 
feedback loop between N-Myc and let-7 is 
present, and if it plays a role in the switch 
between neuronal precursors and 
differentiated cells during neurogenesis.    
 
Another important interactor with the 
MYCN 3´UTR is the neuronal ELAV-like 
protein HuD. ELAV proteins stabilize 
mRNA by binding to AU-rich elements 
(AREs) and replacing proteins that 
promote mRNA degradation. Several 
binding sites for HuD exist in MYCN 
(Monohar et al. 2002). Although 
prevention of ARE-mediated decay seems 
to be a general function, there are some 
discrepancies about this binding. Since 
HuD was found to be highly expressed in 
some neuroendocrine tumors (Chagnovich 
et al. 1996), it was suggested that it 
stabilizes MYCN mRNA. HuD antisense 
treatment decreased HuD expression and 
increased N-Myc levels in these cells 
(Manohar et al. 2002). Recently, 
neuroendocrine lung cancers were 
associated with a HuD mutation that 
probably rendered it incapable of binding 
RNA (D’Alessandro et al. 2009). Thus, it 
can be speculated that the effect of HuD 
overexpression on MYCN stability is 
altered in these tumors. Another scenario 
was proposed reasoning that because the 
HuD gene (ELAV4) is often deleted in 
MYCN amplified neuroblastoma, this 
would be the reason for MYCN 
amplification (Grandinetti et. al. 2006). In 
this model, HuD loss causes all cells 
without MYCN amplification to die 
(because N-Myc is essential during 
neuronal development) and a rapid 
selection for cells with abnormal amounts 
of MYCN copy number (and hence 
sufficient amounts of mRNA) would occur. 
It should not be taken for certain that HuD 
has a positive role in MYCN mRNA 
stabilization, however. This was the case 
with c-Myc and the ubiquitous HuD 
homolog HuR, that had been identified to 
bind c-Myc mRNA. Only recently the 
importance of this interaction was revealed; 
HuR recruits let-7 and its associated Ago2, 
promoting c-Myc degradation instead of 
stabilization (Kim et al. 2009). Perhaps 
exists a similar relationship between 
MYCN and HuD/let-7. In support of this, 
HuD promotes terminal differentiation of 
neurons (reviewed by Deschenes-Furry et 
al. 2006). Furthermore, neurons are the 
only cells that express HuD, while they are 
completely devoid of N-Myc but a specific 
residence of mature let-7 in the nervous 
system cell population (Wulczyn et al. 
2007). In contrast to HuB, neuronal 
progenitors in HuD double knockout mice 
showed enhanced self-renewal capacity 
and decreased ability to differentiate into 
mature neurons (Akamatsu et al. 2005). 
These results directly contradict a 
stabilizating role of HuD on N-Myc 
mRNA. Does overexpression of defective 
HuD in some tumors exhibit a competive 
inhibitory function and impede proper 
degradation of MYCN, and is a similar 
deregulation achieved by loss of the 
ELAV4 locus? In any case, the significance 
of these interaction in determining MYCN 
mRNA fate needs to be elucidated.    
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